Concepedia

David J. Osborne

DJ

Statistics

Publications

30

Citations

1.3K

H-Index

20

Active since

1976

Affiliations

Eli Lilly (United Kingdom)(Current)

Organic Research Centre

Eli Lilly (United States)

Surrey Satellite Technology (United Kingdom)

National Public Health Laboratory

David J. Osborne is an author at Eli Lilly (United Kingdom) specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryPhysiologyNeuropharmacologyNeuroscienceMetabolomicsNeurochemistryPharmacotherapyNatural Sciences

Publications per year

1976–2004

30

Publications

30

Sulfation of Chondroitin Sulfate in Human Articular Cartilage

Michael T. Bayliss, David J. Osborne, Sandra M. Woodhouse et al. · Journal of Biological Chemistry · 1999 · 204 citations · Full text

Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung

W Dawson, J.R. Boot, Anthony F. Cockerill et al. · Nature · 1976 · 191 citations

Inflammation, Novel Prostaglandins, Inflammatory Lung Disease +7

The separation of chondroitin sulfate disaccharides and hyaluronan oligosaccharides by capillary zone electrophoresis

Stephen Carney, David J. Osborne · Analytical Biochemistry · 1991 · 107 citations

Engineering, Chondroitin Sulfate Disaccharides, Biochemistry +12

Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease

Tracey K. Murray, Marcus J. Messenger, Mark Ward et al. · Pharmacology Biochemistry and Behavior · 2002 · 94 citations

Functional Selectivity, Medicine, Physiology +9

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease

Michael J. O’Neill, Tracey K. Murray, Katherine Whalley et al. · European Journal of Pharmacology · 2004 · 61 citations

Neurophysiology, Medicine, Physiology +11

1–5 of 30